GJB5
Gap junction beta-5 protein
Also known as: CX31.1, CXB5_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O95377
- Gene
- GJB5
- Ensembl
- ENSG00000189280
- Chromosome
- 1
- Canonical length
- 273 aa
- Protein class
- Cancer-related genes, Predicted membrane proteins
OverviewNCBI Gene
This gene encodes a member of the beta-type (group I) connexin family. The encoded protein is a gap junction protein involved in intercellular communication related to epidermal differentiation and environmental sensing. This gene has been linked to non-small cell lung cancer. [provided by RefSeq, Nov 2012]
Canonical amino-acid sequenceUniProt
273 residues, UniProt reviewed canonical sequence.
>O95377|GJB5
1 MNWSIFEGLL SGVNKYSTAF GRIWLSLVFI FRVLVYLVTA ERVWSDDHKD FDCNTRQPGC
61 SNVCFDEFFP VSHVRLWALQ LILVTCPSLL VVMHVAYREV QEKRHREAHG ENSGRLYLNP
121 GKKRGGLWWT YVCSLVFKAS VDIAFLYVFH SFYPKYILPP VVKCHADPCP NIVDCFISKP
181 SEKNIFTLFM VATAAICILL NLVELIYLVS KRCHECLAAR KAQAMCTGHH PHGTTSSCKQ
241 DDLLSGDLIF LGSDSHPPLL PDRPRDHVKK TILLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GJB5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 4
- Mean surface accessibility (rSASA)
- 0.39
- Highest tissue expression
- 98 nTPM
Expression across tissuesHPA
Tissue
- esophagus: 98 nTPM
- skin: 91 nTPM
- vagina: 34 nTPM
- cervix: 21 nTPM
- salivary gland: 13 nTPM
- tonsil: 12 nTPM
Single-cell type
- esophageal apical cells: 422 nCPM
- esophageal suprabasal cells: 302 nCPM
- esophageal basal cells: 146 nCPM
- suprabasal keratinocytes: 102 nCPM
- ocular epithelial cells: 58 nCPM
- basal keratinocytes: 52 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- hippocampal formation: 3.1 nTPM
- cerebral cortex: 2.9 nTPM
- amygdala: 2.3 nTPM
- white matter: 1.9 nTPM
- basal ganglia: 1.5 nTPM
- thalamus: 1.5 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.83
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.05
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell-cell signaling
- epidermis development
- labyrinthine layer morphogenesis
- trophoblast giant cell differentiation
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Connexin
- Connexin, N-terminal
- Connexin, conserved site
- Connexin, cysteine-rich domain
- Connexin, N-terminal domain superfamily
- Connexin
- Gap junction beta-5 protein (Cx31.1)
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GJB5 as an antibody target. Whether an autoantibody or antibody against GJB5 could matter depends on whether native GJB5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GJB5 is annotated at the cell surface, where native GJB5 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label GJB5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...